Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Cash from Investing Activities
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
|
Cash from Investing Activities
-¥568.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-13%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Investing Activities
-¥5.9B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash from Investing Activities
-¥2.1B
|
CAGR 3-Years
-42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-31%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Investing Activities
¥73.3m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Investing Activities
¥518.6m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
6%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Cash from Investing Activities
-¥93m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
See Also
What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Cash from Investing Activities?
Cash from Investing Activities
-568.9m
CNY
Based on the financial report for Dec 31, 2023, Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Cash from Investing Activities amounts to -568.9m CNY.
What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-13%
Over the last year, the Cash from Investing Activities growth was -4 533%.